TLDR Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.
Recurrent implantation failure (RIF) is a complex condition characterized by the failure to achieve pregnancy after transferring at least three good-quality embryos in women under 40. The document explores various risk factors, including high BMI, smoking, alcohol, and stress, and highlights the role of uterine natural killer (uNK) cells in maternal-fetal immune tolerance and angiogenesis. Imbalances in immune cells, thrombophilias, and anatomical abnormalities like fibroids and endometriosis are also discussed. Treatment strategies include lifestyle changes, medical interventions, and therapies like intralipid therapy, lymphocyte immunization, and anticoagulants. Promising treatments such as platelet-rich plasma (PRP), granulocyte colony-stimulating factor (G-CSF), and antibiotics for chronic endometritis are noted, but further research is needed to establish effective protocols.
44 citations
,
May 2022 in “Journal of Assisted Reproduction and Genetics”
37 citations
,
May 2018 in “Journal of Cosmetic Dermatology” PRP shows promise for hair loss treatment, but needs standardized preparation and composition.
60 citations
,
September 2016 in “Dermatologic Surgery” PRP treatment may stimulate hair growth by promoting blood vessel formation, increasing growth factors, and preventing cell death.
3 citations
,
May 2023 in “Biomedicines” PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.
August 2014 in “Warwick Research Archive Portal (University of Warwick)” Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.
2 citations
,
October 2015 in “Human Gene Therapy” The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.
24 citations
,
May 2018 in “Journal of Molecular Endocrinology” The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.
6 citations
,
January 2015 in “Journal of regenerative medicine & tissue engineering” The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.